Post exposure prophylaxis antibiotics: Difference between revisions
Ostermayer (talk | contribs) (Text replacement - "Category:Drugs" to "Category:Pharmacology") |
Ostermayer (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
==Hepatitis B== | |||
''Treatment is generally initiated after coordination with occupational health and infectious disease service and based the the exposed patient's vaccination history''<ref> Postexposure prophylaxis to prevent hepatitis b virus infection. CDC MMWR http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5516a3.htm?s_cid=rr5516a3_e</ref> | |||
===Unvaccinated=== | |||
*If the source is HBsAg(+) then give HBIG x1 and initiate HBV vaccine in two separate sites | |||
*If source is HGsAG(-) then start the HBV vaccine series | |||
*If source blood is unavailable and high risk then give HBIG x1 initiate the HBV series | |||
**If source blood is low risk and unavailable then begin HBV series | |||
===Previously vaccinated non responder (one series)=== | |||
''Non responder status is defined as anti-has <10mIU/mL'' | |||
*If the source is HBsAg(+) then give HBIG x 1 and begin revaccination series | |||
**Can also opt to perform second HBIG administration in one month | |||
*If source is HBsAg(-) then no treatment is needed | |||
*If source blood is unavailable and high risk then treat as if HBsAg(+) | |||
===Previously vaccinated non responder (two series)=== | |||
''Non responder status is defined as anti-has <10mIU/mL'' | |||
*If the source is HBsAg(+) then give HBIG x2 and no HBV series | |||
*If source is HGsAG(-) then no treatment is needed | |||
*If source blood is unavailable then initiate the HBV series | |||
==See Also== | |||
{{Antibiotics by diagnosis navigation}} | {{Antibiotics by diagnosis navigation}} | ||
Revision as of 16:02, 22 May 2016
Hepatitis B
Treatment is generally initiated after coordination with occupational health and infectious disease service and based the the exposed patient's vaccination history[1]
Unvaccinated
- If the source is HBsAg(+) then give HBIG x1 and initiate HBV vaccine in two separate sites
- If source is HGsAG(-) then start the HBV vaccine series
- If source blood is unavailable and high risk then give HBIG x1 initiate the HBV series
- If source blood is low risk and unavailable then begin HBV series
Previously vaccinated non responder (one series)
Non responder status is defined as anti-has <10mIU/mL
- If the source is HBsAg(+) then give HBIG x 1 and begin revaccination series
- Can also opt to perform second HBIG administration in one month
- If source is HBsAg(-) then no treatment is needed
- If source blood is unavailable and high risk then treat as if HBsAg(+)
Previously vaccinated non responder (two series)
Non responder status is defined as anti-has <10mIU/mL
- If the source is HBsAg(+) then give HBIG x2 and no HBV series
- If source is HGsAG(-) then no treatment is needed
- If source blood is unavailable then initiate the HBV series
See Also
Antibiotics by diagnosis
- Bone and joint antibiotics
- Cardiovascular antibiotics
- ENT antibiotics
- Eye antibiotics
- GI antibiotics
- GU antibiotics
- Neuro antibiotics
- OB/GYN antibiotics
- Pulmonary antibiotics
- Skin and soft tissue antibiotics
- Bioterrorism antibiotics
- Environmental exposure antibiotics
- Immunocompromised antibiotics
- Post exposure prophylaxis antibiotics
- Pediatric antibiotics
- Sepsis antibiotics
- Arthropod and parasitic antibiotics
For antibiotics by organism see Microbiology (Main)
References
- ↑ Postexposure prophylaxis to prevent hepatitis b virus infection. CDC MMWR http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5516a3.htm?s_cid=rr5516a3_e
